Cargando…
Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
Advanced Therapeutic Medicinal Products (ATMP) are a heterogenous group of investigational medicinal products at the forefront of innovative therapies with direct applicability in respiratory diseases. ATMPs include, but are not limited to, stem cells, their secretome, or extracellular vesicles, and...
Autores principales: | Woods, Niamh, MacLoughlin, Ronan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601063/ https://www.ncbi.nlm.nih.gov/pubmed/32993197 http://dx.doi.org/10.3390/pharmaceutics12100922 |
Ejemplares similares
-
State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery
por: Brave, Hosanna, et al.
Publicado: (2020) -
Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy
por: Bennett, Gavin, et al.
Publicado: (2019) -
A narrative review on trans-nasal pulmonary aerosol delivery
por: Li, Jie, et al.
Publicado: (2020) -
In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
por: Bennett, Gavin, et al.
Publicado: (2019) -
The Impact of Head Model Choice on the In Vitro Evaluation of Aerosol Drug Delivery
por: Gallagher, Lauren, et al.
Publicado: (2021)